# pathway_0198: before and after transfer clarification

[All 1,328 cases](../README.md) · [Method](../METHOD.md) · [Summary](../SUMMARY.md) · [Exact reviewer user message](../inputs/pathway_0198.txt)

**Task:** `pathway`  
**Author key, unchanged:** **C** — Antifungal biosynthesis. .

| Round | Reviewer | Key support | Transfer / lookup | Output usability (canonical status) |
|---|---|---|---|---|
| before | GPT-6 Luna | supported | lookup-dependent | usable output (valid_review) |
| before | Qwen3.8-Flash-Next-NVFP4 | supported | lookup-dependent | usable output (valid_review) |
| after | GPT-6 Luna | supported | lookup-dependent | usable output (valid_review) |
| after | Qwen3.8-Flash-Next-NVFP4 | supported | reasoning-supported | usable output (valid_review) |

**Usable output means format-valid review, not reasoning-supported or biologically correct.** A usable output can classify the question as reasoning-supported, lookup-dependent or uncertain. An output error is a problem with the saved model response; it does not count a defective benchmark question or wrong key. Each saved review is retained in full below. Labels from output errors are displayed as saved and excluded from label statistics. The author key and reviewer evidence were visible to reviewers; this is a review of answerability and key support, not a benchmark-solving score.

## Complete original question

```text
[Protein Sequence]
MPRPVSVVFVSLIIAAAVGVWGVFAWNGGFEELDAIVNRHPSTGIPGLNHFPSLDQGLMSMAAFNLPVVGREPLFAEGRHFMAQLLANVFAIPIVLLTEDFRAAPGSVARYSTSWGVFSQLATSAVMCPLYGVCFSRRSNPRRVAVLPGRSTWIVLISVLIGYGAPAMLIFDPFSWGLKPQIWGVLAFTVYPLYVCLTASLLLKTVSSKRGRASRSVQKDSDSNSSLHYVVAGIVGVAGHLSYIGFHLGEHTGTAATRPDRVAQLVLRFLQIDYVITFAAMLTLAWHELTHSGRISLKPWRVAGYLLLGWLFIGPGATLAAAWALRERWIRQDTQEEKKRKL

[Multiple Choices]
A. Cell wall biogenesis
B. glycosylphosphatidylinositol-anchor biosynthesis. .
C. Antifungal biosynthesis. .
D. deamido-NAD(+) from nicotinate D-ribonucleotide: step 1/1. .
```

<details>
<summary>Complete original system instructions</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Protein Pathway Prediction, which is to predict the primary metabolic or signaling pathway in which a given protein functions. Biological pathways are series of chemical reactions occurring within a cell that are essential for life. Based on the protein's amino acid sequence, you should identify the most relevant pathway from the given options.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## Four saved visible reviews

## Before: GPT-6 Luna

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The supplied sequence exactly matches the UniProt entry for terpene cyclase ResF, annotated in the antifungal biosynthesis pathway. The pathway annotation cites experimental evidence (ECO:0000269) and a 2024 paper; this supports choice C, though the cited study was not independently reviewed here.

Citations as saved: [C1](#evidence-c1), [C4](#evidence-c4), [C5](#evidence-c5), [C6](#evidence-c6), [H3](#evidence-h3).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The sequence is rich in hydrophobic regions, but that alone does not identify a specific biosynthetic pathway or distinguish antifungal biosynthesis from the listed alternatives.


**Missing item-specific fact**

> The protein-specific fact that this exact sequence is ResF, a terpene cyclase associated with antifungal biosynthesis, is absent from the input.


**Reason**

> The key is supported by a sequence-matched database annotation linked to a publication, but selecting it from the sequence and choices requires that external protein-specific functional or pathway information.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The sequence-matched annotation supports C; no evidence here supports another listed choice. However, the input alone does not provide enough information to distinguish the options.


### Important caveats

- The reviewer-only UniProt annotation and source identity were not supplied to the evaluated model.
- The source associates the pathway annotation with experimental evidence, but the primary paper was not independently assessed.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence is rich in hydrophobic regions, but that alone does not identify a specific biosynthetic pathway or distinguish antifungal biosynthesis from the listed alternatives.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The protein-specific fact that this exact sequence is ResF, a terpene cyclase associated with antifungal biosynthesis, is absent from the input.",
    "reason": "The key is supported by a sequence-matched database annotation linked to a publication, but selecting it from the sequence and choices requires that external protein-specific functional or pathway information."
  },
  "case_id": "pathway_0198",
  "expected_answer_check": {
    "evidence_ids": [
      "C1",
      "C4",
      "C5",
      "C6",
      "H3"
    ],
    "judgment": "supported",
    "reason": "The supplied sequence exactly matches the UniProt entry for terpene cyclase ResF, annotated in the antifungal biosynthesis pathway. The pathway annotation cites experimental evidence (ECO:0000269) and a 2024 paper; this supports choice C, though the cited study was not independently reviewed here."
  },
  "important_caveats": [
    "The reviewer-only UniProt annotation and source identity were not supplied to the evaluated model.",
    "The source associates the pathway annotation with experimental evidence, but the primary paper was not independently assessed."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The sequence-matched annotation supports C; no evidence here supports another listed choice. However, the input alone does not provide enough information to distinguish the options."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "pathway_0198",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The supplied sequence exactly matches the UniProt entry for terpene cyclase ResF, annotated in the antifungal biosynthesis pathway. The pathway annotation cites experimental evidence (ECO:0000269) and a 2024 paper; this supports choice C, though the cited study was not independently reviewed here.",
    "evidence_ids": ["C1", "C4", "C5", "C6", "H3"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The sequence is rich in hydrophobic regions, but that alone does not identify a specific biosynthetic pathway or distinguish antifungal biosynthesis from the listed alternatives.",
    "missing_item_specific_fact": "The protein-specific fact that this exact sequence is ResF, a terpene cyclase associated with antifungal biosynthesis, is absent from the input.",
    "reason": "The key is supported by a sequence-matched database annotation linked to a publication, but selecting it from the sequence and choices requires that external protein-specific functional or pathway information."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The sequence-matched annotation supports C; no evidence here supports another listed choice. However, the input alone does not provide enough information to distinguish the options."
  },
  "important_caveats": [
    "The reviewer-only UniProt annotation and source identity were not supplied to the evaluated model.",
    "The source associates the pathway annotation with experimental evidence, but the primary paper was not independently assessed."
  ]
}
```

</details>

## Before: Qwen3.8-Flash-Next-NVFP4

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> UniProt entry P0DXW0 (sequence exactly matched, 342 aa) annotates the pathway as 'Antifungal biosynthesis' with evidence code ECO:0000269 (experimental evidence) from PubMed:39105744. The protein is named 'Terpene cyclase resF' / 'Restricticin biosynthesis cluster protein F' from Aspergillus sclerotiorum, and restricticin is a secondary metabolite with antifungal activity. The expected answer C directly matches the curated UniProt pathway annotation.

Citations as saved: [C1](#evidence-c1), [C4](#evidence-c4), [C5](#evidence-c5), [C6](#evidence-c6), [H1](#evidence-h1), [H3](#evidence-h3).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The sequence contains multiple hydrophobic stretches and a possible N-terminal signal peptide, but these features are generic to many membrane-associated or secreted proteins and do not uniquely point to terpene cyclase activity or antifungal secondary-metabolite biosynthesis. No canonical terpene cyclase motifs (e.g., DxxDTE, NSE/DTE) are readily identifiable from the raw linear sequence without structural context. Even if a terpene cyclase were recognized, connecting it specifically to 'Antifungal biosynthesis' (i.e., restricticin production) rather than other terpene-related pathways requires knowledge of the specific biosynthetic cluster and product activity.


**Missing item-specific fact**

> The identity of this protein as resF, a terpene cyclase in the restricticin biosynthetic gene cluster of Aspergillus sclerotiorum, and the experimental demonstration (PubMed:39105744) that restricticin exhibits antifungal activity, are all item-specific facts absent from the supplied sequence and question. Without memorizing the UniProt annotation or the primary literature, the four choices cannot be meaningfully distinguished by general biological reasoning.


**Reason**

> The question provides only a raw amino acid sequence and four pathway labels. None of the sequence features (hydrophobic regions, signal-peptide-like N-terminus, overall length) provide a concrete biological argument that uniquely selects 'Antifungal biosynthesis' over the other three options. The correct answer depends on knowing the specific gene cluster (resF in the restricticin BGC) and the experimentally demonstrated antifungal bioactivity of restricticin, which is a protein-specific annotation fact.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The distractors (cell wall biogenesis, GPI-anchor biosynthesis, NAD+ biosynthesis) do not closely match the sequence's features either, so there is no strong ambiguity among the choices. However, the correct answer is not derivable from the sequence alone; it requires the specific database annotation.


### Important caveats

- The UniProt pathway annotation carries evidence code ECO:0000269 (experimental), lending reasonable support to the key.
- The entry was first released in February 2025; the author's source snapshot date is unknown, so the annotation may or may not have been available at benchmark construction time.
- 'Antifungal biosynthesis' is a non-standard, project-specific pathway label rather than a canonical metabolic pathway name (e.g., KEGG or MetaCyc), making it even harder to reason toward without the exact annotation.
- The organism (Aspergillus sclerotiorum) is not provided in the question, removing a potential contextual clue that the protein might be involved in fungal secondary metabolism.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence contains multiple hydrophobic stretches and a possible N-terminal signal peptide, but these features are generic to many membrane-associated or secreted proteins and do not uniquely point to terpene cyclase activity or antifungal secondary-metabolite biosynthesis. No canonical terpene cyclase motifs (e.g., DxxDTE, NSE/DTE) are readily identifiable from the raw linear sequence without structural context. Even if a terpene cyclase were recognized, connecting it specifically to 'Antifungal biosynthesis' (i.e., restricticin production) rather than other terpene-related pathways requires knowledge of the specific biosynthetic cluster and product activity.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The identity of this protein as resF, a terpene cyclase in the restricticin biosynthetic gene cluster of Aspergillus sclerotiorum, and the experimental demonstration (PubMed:39105744) that restricticin exhibits antifungal activity, are all item-specific facts absent from the supplied sequence and question. Without memorizing the UniProt annotation or the primary literature, the four choices cannot be meaningfully distinguished by general biological reasoning.",
    "reason": "The question provides only a raw amino acid sequence and four pathway labels. None of the sequence features (hydrophobic regions, signal-peptide-like N-terminus, overall length) provide a concrete biological argument that uniquely selects 'Antifungal biosynthesis' over the other three options. The correct answer depends on knowing the specific gene cluster (resF in the restricticin BGC) and the experimentally demonstrated antifungal bioactivity of restricticin, which is a protein-specific annotation fact."
  },
  "case_id": "pathway_0198",
  "expected_answer_check": {
    "evidence_ids": [
      "C1",
      "C4",
      "C5",
      "C6",
      "H1",
      "H3"
    ],
    "judgment": "supported",
    "reason": "UniProt entry P0DXW0 (sequence exactly matched, 342 aa) annotates the pathway as 'Antifungal biosynthesis' with evidence code ECO:0000269 (experimental evidence) from PubMed:39105744. The protein is named 'Terpene cyclase resF' / 'Restricticin biosynthesis cluster protein F' from Aspergillus sclerotiorum, and restricticin is a secondary metabolite with antifungal activity. The expected answer C directly matches the curated UniProt pathway annotation."
  },
  "important_caveats": [
    "The UniProt pathway annotation carries evidence code ECO:0000269 (experimental), lending reasonable support to the key.",
    "The entry was first released in February 2025; the author's source snapshot date is unknown, so the annotation may or may not have been available at benchmark construction time.",
    "'Antifungal biosynthesis' is a non-standard, project-specific pathway label rather than a canonical metabolic pathway name (e.g., KEGG or MetaCyc), making it even harder to reason toward without the exact annotation.",
    "The organism (Aspergillus sclerotiorum) is not provided in the question, removing a potential contextual clue that the protein might be involved in fungal secondary metabolism."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The distractors (cell wall biogenesis, GPI-anchor biosynthesis, NAD+ biosynthesis) do not closely match the sequence's features either, so there is no strong ambiguity among the choices. However, the correct answer is not derivable from the sequence alone; it requires the specific database annotation."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "pathway_0198",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "UniProt entry P0DXW0 (sequence exactly matched, 342 aa) annotates the pathway as 'Antifungal biosynthesis' with evidence code ECO:0000269 (experimental evidence) from PubMed:39105744. The protein is named 'Terpene cyclase resF' / 'Restricticin biosynthesis cluster protein F' from Aspergillus sclerotiorum, and restricticin is a secondary metabolite with antifungal activity. The expected answer C directly matches the curated UniProt pathway annotation.",
    "evidence_ids": ["C1", "C4", "C5", "C6", "H1", "H3"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The sequence contains multiple hydrophobic stretches and a possible N-terminal signal peptide, but these features are generic to many membrane-associated or secreted proteins and do not uniquely point to terpene cyclase activity or antifungal secondary-metabolite biosynthesis. No canonical terpene cyclase motifs (e.g., DxxDTE, NSE/DTE) are readily identifiable from the raw linear sequence without structural context. Even if a terpene cyclase were recognized, connecting it specifically to 'Antifungal biosynthesis' (i.e., restricticin production) rather than other terpene-related pathways requires knowledge of the specific biosynthetic cluster and product activity.",
    "missing_item_specific_fact": "The identity of this protein as resF, a terpene cyclase in the restricticin biosynthetic gene cluster of Aspergillus sclerotiorum, and the experimental demonstration (PubMed:39105744) that restricticin exhibits antifungal activity, are all item-specific facts absent from the supplied sequence and question. Without memorizing the UniProt annotation or the primary literature, the four choices cannot be meaningfully distinguished by general biological reasoning.",
    "reason": "The question provides only a raw amino acid sequence and four pathway labels. None of the sequence features (hydrophobic regions, signal-peptide-like N-terminus, overall length) provide a concrete biological argument that uniquely selects 'Antifungal biosynthesis' over the other three options. The correct answer depends on knowing the specific gene cluster (resF in the restricticin BGC) and the experimentally demonstrated antifungal bioactivity of restricticin, which is a protein-specific annotation fact."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The distractors (cell wall biogenesis, GPI-anchor biosynthesis, NAD+ biosynthesis) do not closely match the sequence's features either, so there is no strong ambiguity among the choices. However, the correct answer is not derivable from the sequence alone; it requires the specific database annotation."
  },
  "important_caveats": [
    "The UniProt pathway annotation carries evidence code ECO:0000269 (experimental), lending reasonable support to the key.",
    "The entry was first released in February 2025; the author's source snapshot date is unknown, so the annotation may or may not have been available at benchmark construction time.",
    "'Antifungal biosynthesis' is a non-standard, project-specific pathway label rather than a canonical metabolic pathway name (e.g., KEGG or MetaCyc), making it even harder to reason toward without the exact annotation.",
    "The organism (Aspergillus sclerotiorum) is not provided in the question, removing a potential contextual clue that the protein might be involved in fungal secondary metabolism."
  ]
}
```

</details>

## After: GPT-6 Luna

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The exact sequence matches the UniProt record, which assigns it to antifungal biosynthesis and attributes that pathway annotation to a publication with experimental evidence (ECO:0000269). This supports C, although the excerpts do not independently show the underlying experiments, and the author’s exact source snapshot is unknown.

Citations as saved: [C5](#evidence-c5), [H3](#evidence-h3).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

Empty string, as saved.


**Missing item-specific fact**

> The protein’s specific identity or biosynthetic-cluster/pathway assignment as a component of antifungal biosynthesis.


**Reason**

> The sequence is strongly hydrophobic and appears compatible with a membrane protein, which may make the specific soluble NAD-pathway option less likely. But that broad feature does not meaningfully distinguish antifungal biosynthesis from the offered cell-wall or GPI-anchor pathways. No recognizable transferable family feature in the supplied input specifically supports C.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The supplied sequence does not establish C over the other plausible membrane-associated pathway choices, but the available evidence does not independently establish another offered choice as correct.


### Important caveats

- The pathway support comes from a database annotation attributed to a publication; the excerpts are not a direct account of the experimental results.
- Reviewer-only protein identity and pathway annotation were not available in the original input and are not used as a transferable inference.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The protein’s specific identity or biosynthetic-cluster/pathway assignment as a component of antifungal biosynthesis.",
    "reason": "The sequence is strongly hydrophobic and appears compatible with a membrane protein, which may make the specific soluble NAD-pathway option less likely. But that broad feature does not meaningfully distinguish antifungal biosynthesis from the offered cell-wall or GPI-anchor pathways. No recognizable transferable family feature in the supplied input specifically supports C."
  },
  "case_id": "pathway_0198",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "H3"
    ],
    "judgment": "supported",
    "reason": "The exact sequence matches the UniProt record, which assigns it to antifungal biosynthesis and attributes that pathway annotation to a publication with experimental evidence (ECO:0000269). This supports C, although the excerpts do not independently show the underlying experiments, and the author’s exact source snapshot is unknown."
  },
  "important_caveats": [
    "The pathway support comes from a database annotation attributed to a publication; the excerpts are not a direct account of the experimental results.",
    "Reviewer-only protein identity and pathway annotation were not available in the original input and are not used as a transferable inference."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The supplied sequence does not establish C over the other plausible membrane-associated pathway choices, but the available evidence does not independently establish another offered choice as correct."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "pathway_0198",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The exact sequence matches the UniProt record, which assigns it to antifungal biosynthesis and attributes that pathway annotation to a publication with experimental evidence (ECO:0000269). This supports C, although the excerpts do not independently show the underlying experiments, and the author’s exact source snapshot is unknown.",
    "evidence_ids": ["C5", "H3"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "",
    "missing_item_specific_fact": "The protein’s specific identity or biosynthetic-cluster/pathway assignment as a component of antifungal biosynthesis.",
    "reason": "The sequence is strongly hydrophobic and appears compatible with a membrane protein, which may make the specific soluble NAD-pathway option less likely. But that broad feature does not meaningfully distinguish antifungal biosynthesis from the offered cell-wall or GPI-anchor pathways. No recognizable transferable family feature in the supplied input specifically supports C."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The supplied sequence does not establish C over the other plausible membrane-associated pathway choices, but the available evidence does not independently establish another offered choice as correct."
  },
  "important_caveats": [
    "The pathway support comes from a database annotation attributed to a publication; the excerpts are not a direct account of the experimental results.",
    "Reviewer-only protein identity and pathway annotation were not available in the original input and are not used as a transferable inference."
  ]
}
```

</details>

## After: Qwen3.8-Flash-Next-NVFP4

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The UniProt entry P0DXW0 (Terpene cyclase resF, Aspergillus sclerotiorum) explicitly annotates the pathway as 'Antifungal biosynthesis' with evidence code ECO:0000269 (direct assay) from PubMed 39105744. The protein is a terpene cyclase in the restricticin biosynthesis cluster. The sequence matches the benchmark input exactly (342 aa, SHA256 confirmed).

Citations as saved: [C1](#evidence-c1), [C3](#evidence-c3), [C4](#evidence-c4), [C5](#evidence-c5), [C6](#evidence-c6), [H1](#evidence-h1), [H3](#evidence-h3).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The protein is 342 aa with a clear N-terminal signal peptide and multiple hydrophobic stretches consistent with a multi-transmembrane membrane-associated enzyme of fungal origin. Among the four options: (D) NAD+ biosynthesis enzymes (e.g., NMN adenylyltransferase, NAD synthase) are small soluble enzymes with Rossmann-like folds, incompatible with this multi-TM architecture. (B) GPI-anchor biosynthesis enzymes are ER-luminal soluble or single-pass membrane proteins, not multi-TM. (A) Cell wall biosynthesis enzymes (chitin synthases, glucan synthases, glycosyltransferases) are typically much larger (>700-1000 aa for synthases) or have distinct GT-A/GT-B folds, inconsistent with a 342-aa multi-TM protein. (C) Antifungal biosynthesis (a secondary metabolite pathway) is the only option consistent with a fungal membrane-associated enzyme of this size and architecture. Fungal terpene cyclases involved in secondary metabolite clusters (e.g., restricticin, terretonin) are known to be ER-membrane-anchored with multiple TM domains, unlike soluble bacterial/plant terpene synthases. The absence of any primary-metabolism enzyme signature (no Rossmann fold, no GT motif, no synthase domain) combined with the multi-TM fungal architecture points specifically to secondary metabolite biosynthesis, which among the given choices is only option C.


**Missing item-specific fact**

Empty string, as saved.


**Reason**

> A knowledgeable model can use the protein's architecture (multi-TM, ~342 aa, fungal signal peptide, absence of primary-metabolism enzyme domains) and general knowledge of fungal secondary metabolite biosynthesis enzymes (which are often membrane-associated, unlike primary metabolism enzymes) to eliminate options A, B, and D, and select C. This is a legitimate family/architecture-based inference learned from other fungal terpene cyclases and secondary metabolite enzymes.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The four options represent distinct biological categories (primary metabolism: cell wall, GPI anchor, NAD+; secondary metabolism: antifungal). The protein's architecture clearly excludes the three primary-metabolism options, leaving C as the only defensible choice.


### Important caveats

- The pathway name 'Antifungal biosynthesis' is a UniProt-specific annotation for secondary metabolite clusters and is not a standard KEGG/MetaCyc pathway name; a model unfamiliar with this naming convention might not recognize it as a valid pathway category.
- The positive identification as a terpene cyclase specifically (vs. other secondary metabolite enzymes) from sequence alone is difficult without a clearly recognizable DDxxD motif, but the question only requires distinguishing among the four given options, not identifying the exact enzyme class.
- The entry was first published in 2025, so it is a very recent annotation; however, the reasoning relies on general architectural principles applicable to many fungal secondary metabolite enzymes, not on memorizing this specific entry.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The protein is 342 aa with a clear N-terminal signal peptide and multiple hydrophobic stretches consistent with a multi-transmembrane membrane-associated enzyme of fungal origin. Among the four options: (D) NAD+ biosynthesis enzymes (e.g., NMN adenylyltransferase, NAD synthase) are small soluble enzymes with Rossmann-like folds, incompatible with this multi-TM architecture. (B) GPI-anchor biosynthesis enzymes are ER-luminal soluble or single-pass membrane proteins, not multi-TM. (A) Cell wall biosynthesis enzymes (chitin synthases, glucan synthases, glycosyltransferases) are typically much larger (>700-1000 aa for synthases) or have distinct GT-A/GT-B folds, inconsistent with a 342-aa multi-TM protein. (C) Antifungal biosynthesis (a secondary metabolite pathway) is the only option consistent with a fungal membrane-associated enzyme of this size and architecture. Fungal terpene cyclases involved in secondary metabolite clusters (e.g., restricticin, terretonin) are known to be ER-membrane-anchored with multiple TM domains, unlike soluble bacterial/plant terpene synthases. The absence of any primary-metabolism enzyme signature (no Rossmann fold, no GT motif, no synthase domain) combined with the multi-TM fungal architecture points specifically to secondary metabolite biosynthesis, which among the given choices is only option C.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "",
    "reason": "A knowledgeable model can use the protein's architecture (multi-TM, ~342 aa, fungal signal peptide, absence of primary-metabolism enzyme domains) and general knowledge of fungal secondary metabolite biosynthesis enzymes (which are often membrane-associated, unlike primary metabolism enzymes) to eliminate options A, B, and D, and select C. This is a legitimate family/architecture-based inference learned from other fungal terpene cyclases and secondary metabolite enzymes."
  },
  "case_id": "pathway_0198",
  "expected_answer_check": {
    "evidence_ids": [
      "C1",
      "C3",
      "C4",
      "C5",
      "C6",
      "H1",
      "H3"
    ],
    "judgment": "supported",
    "reason": "The UniProt entry P0DXW0 (Terpene cyclase resF, Aspergillus sclerotiorum) explicitly annotates the pathway as 'Antifungal biosynthesis' with evidence code ECO:0000269 (direct assay) from PubMed 39105744. The protein is a terpene cyclase in the restricticin biosynthesis cluster. The sequence matches the benchmark input exactly (342 aa, SHA256 confirmed)."
  },
  "important_caveats": [
    "The pathway name 'Antifungal biosynthesis' is a UniProt-specific annotation for secondary metabolite clusters and is not a standard KEGG/MetaCyc pathway name; a model unfamiliar with this naming convention might not recognize it as a valid pathway category.",
    "The positive identification as a terpene cyclase specifically (vs. other secondary metabolite enzymes) from sequence alone is difficult without a clearly recognizable DDxxD motif, but the question only requires distinguishing among the four given options, not identifying the exact enzyme class.",
    "The entry was first published in 2025, so it is a very recent annotation; however, the reasoning relies on general architectural principles applicable to many fungal secondary metabolite enzymes, not on memorizing this specific entry."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The four options represent distinct biological categories (primary metabolism: cell wall, GPI anchor, NAD+; secondary metabolism: antifungal). The protein's architecture clearly excludes the three primary-metabolism options, leaving C as the only defensible choice."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{"case_id":"pathway_0198","expected_answer_check":{"judgment":"supported","reason":"The UniProt entry P0DXW0 (Terpene cyclase resF, Aspergillus sclerotiorum) explicitly annotates the pathway as 'Antifungal biosynthesis' with evidence code ECO:0000269 (direct assay) from PubMed 39105744. The protein is a terpene cyclase in the restricticin biosynthesis cluster. The sequence matches the benchmark input exactly (342 aa, SHA256 confirmed).","evidence_ids":["C1","C3","C4","C5","C6","H1","H3"]},"answerability_check":{"judgment":"reasoning_supported","discriminating_biological_argument":"The protein is 342 aa with a clear N-terminal signal peptide and multiple hydrophobic stretches consistent with a multi-transmembrane membrane-associated enzyme of fungal origin. Among the four options: (D) NAD+ biosynthesis enzymes (e.g., NMN adenylyltransferase, NAD synthase) are small soluble enzymes with Rossmann-like folds, incompatible with this multi-TM architecture. (B) GPI-anchor biosynthesis enzymes are ER-luminal soluble or single-pass membrane proteins, not multi-TM. (A) Cell wall biosynthesis enzymes (chitin synthases, glucan synthases, glycosyltransferases) are typically much larger (>700-1000 aa for synthases) or have distinct GT-A/GT-B folds, inconsistent with a 342-aa multi-TM protein. (C) Antifungal biosynthesis (a secondary metabolite pathway) is the only option consistent with a fungal membrane-associated enzyme of this size and architecture. Fungal terpene cyclases involved in secondary metabolite clusters (e.g., restricticin, terretonin) are known to be ER-membrane-anchored with multiple TM domains, unlike soluble bacterial/plant terpene synthases. The absence of any primary-metabolism enzyme signature (no Rossmann fold, no GT motif, no synthase domain) combined with the multi-TM fungal architecture points specifically to secondary metabolite biosynthesis, which among the given choices is only option C.","missing_item_specific_fact":"","reason":"A knowledgeable model can use the protein's architecture (multi-TM, ~342 aa, fungal signal peptide, absence of primary-metabolism enzyme domains) and general knowledge of fungal secondary metabolite biosynthesis enzymes (which are often membrane-associated, unlike primary metabolism enzymes) to eliminate options A, B, and D, and select C. This is a legitimate family/architecture-based inference learned from other fungal terpene cyclases and secondary metabolite enzymes."},"question_ambiguity":{"multiple_defensible_options":[],"reason":"The four options represent distinct biological categories (primary metabolism: cell wall, GPI anchor, NAD+; secondary metabolism: antifungal). The protein's architecture clearly excludes the three primary-metabolism options, leaving C as the only defensible choice."},"important_caveats":["The pathway name 'Antifungal biosynthesis' is a UniProt-specific annotation for secondary metabolite clusters and is not a standard KEGG/MetaCyc pathway name; a model unfamiliar with this naming convention might not recognize it as a valid pathway category.","The positive identification as a terpene cyclase specifically (vs. other secondary metabolite enzymes) from sequence alone is difficult without a clearly recognizable DDxxD motif, but the question only requires distinguishing among the four given options, not identifying the exact enzyme class.","The entry was first published in 2025, so it is a very recent annotation; however, the reasoning relies on general architectural principles applicable to many fungal secondary metabolite enzymes, not on memorizing this specific entry."]}
```

</details>

## Existing project source checks of the old Luna review only

These unchanged notes concern the earlier Luna claims. They do not validate either new review or the old Qwen review. No new scientific adjudication was performed.

## Project source-check notes

These project-authored, AI-assisted checks assess specific source claims. They are not expert adjudication and do not replace Luna’s saved review or the author key.

No additional case-specific project note was recorded. Citation membership checks do not establish that every scientific argument is correct.

## Complete reviewer-only evidence and qualifications

All excerpts supplied in the original and revised reviewer user message follow. This material was not available to the original evaluated model. Accession identity came from dataset image-path metadata. Source support and transferable discrimination are separate judgments.

**Applicability metadata, unchanged:**

```json
{
  "requested_accession": "P0DXW0",
  "identity_origin": "reviewer-only accession inferred mechanically from original dataset image-path metadata; this accession/metadata was absent from evaluated model input",
  "benchmark_sequence_sha256": "ed325be2f8ee79598c0abcb873dca733c54a3c7abec00f6bf398603cd44c5b21",
  "benchmark_sequence_length": 342,
  "current_status": "retrieved",
  "current_sequence_comparison": "matched",
  "current_entry_audit": {
    "entryVersion": 4,
    "firstPublicDate": "2025-02-05",
    "lastAnnotationUpdateDate": "2026-09-02",
    "lastSequenceUpdateDate": "2025-02-05",
    "sequenceVersion": 1
  },
  "current_uniprot_release": "2026_03",
  "current_record_sha256": "20826975e15383c7e7ed9a18e9833743bdc1e763a65798dcc5e4dbb145fcc991",
  "current_source_sequence_sha256": "ed325be2f8ee79598c0abcb873dca733c54a3c7abec00f6bf398603cd44c5b21",
  "current_source_sequence_length": 342,
  "historical_status": "retrieved",
  "historical_cutoff_date": "2026-05-07",
  "historical_sequence_comparison": "matched",
  "selected_historical_entry_version": 2,
  "selected_historical_version": {
    "accession": "P0DXW0",
    "database": "Swiss-Prot",
    "entryVersion": 2,
    "firstRelease": "2025_02/2025_02",
    "firstReleaseDate": "23-Apr-2025",
    "lastRelease": "2026_01/2026_01",
    "lastReleaseDate": "28-Jan-2026",
    "name": "RESF_ASPSL",
    "sequenceVersion": 1
  },
  "selected_historical_record_sha256": "4ee0148ff929a45fee99461aa9272fe9ea0eed8e9ecc9ee53739e76044ec61c4",
  "selected_historical_source_sequence_sha256": "ed325be2f8ee79598c0abcb873dca733c54a3c7abec00f6bf398603cd44c5b21",
  "selected_historical_source_sequence_length": 342,
  "latest_at_cutoff_sequence_comparison": "matched",
  "historical_sequence_versions_checked": [
    {
      "entry_version": 2,
      "exact_sequence_comparison": "matched",
      "sequence_version": 1
    }
  ],
  "actual_author_source_snapshot": "unknown",
  "numbering": "Canonical entry coordinates; construct or isoform numbering is not assumed."
}
```

**Qualifications, unchanged:**

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.

### Evidence C1

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P0DXW0.json)

```json
{
  "evidence_id": "C1",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/P0DXW0.json",
  "source_sha256": "20826975e15383c7e7ed9a18e9833743bdc1e763a65798dcc5e4dbb145fcc991",
  "retrieved_utc": "2026-11-02T04:29:50.537709+00:00",
  "json_pointer": "/primaryAccession",
  "excerpt": "\"P0DXW0\"",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C2

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P0DXW0.json)

```json
{
  "evidence_id": "C2",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/P0DXW0.json",
  "source_sha256": "20826975e15383c7e7ed9a18e9833743bdc1e763a65798dcc5e4dbb145fcc991",
  "retrieved_utc": "2026-11-02T04:29:50.537709+00:00",
  "json_pointer": "/entryAudit",
  "excerpt": "{\"entryVersion\":4,\"firstPublicDate\":\"2025-02-05\",\"lastAnnotationUpdateDate\":\"2026-09-02\",\"lastSequenceUpdateDate\":\"2025-02-05\",\"sequenceVersion\":1}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C3

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P0DXW0.json)

```json
{
  "evidence_id": "C3",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/P0DXW0.json",
  "source_sha256": "20826975e15383c7e7ed9a18e9833743bdc1e763a65798dcc5e4dbb145fcc991",
  "retrieved_utc": "2026-11-02T04:29:50.537709+00:00",
  "json_pointer": "/organism",
  "excerpt": "{\"lineage\":[\"Eukaryota\",\"Fungi\",\"Dikarya\",\"Ascomycota\",\"Pezizomycotina\",\"Eurotiomycetes\",\"Eurotiomycetidae\",\"Eurotiales\",\"Aspergillaceae\",\"Aspergillus\",\"Circumdati\"],\"scientificName\":\"Aspergillus sclerotiorum\",\"taxonId\":138282}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C4

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P0DXW0.json)

```json
{
  "evidence_id": "C4",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/P0DXW0.json",
  "source_sha256": "20826975e15383c7e7ed9a18e9833743bdc1e763a65798dcc5e4dbb145fcc991",
  "retrieved_utc": "2026-11-02T04:29:50.537709+00:00",
  "json_pointer": "/proteinDescription",
  "excerpt": "{\"alternativeNames\":[{\"fullName\":{\"evidences\":[{\"evidenceCode\":\"ECO:0000303\",\"id\":\"39105744\",\"source\":\"PubMed\"}],\"value\":\"Restricticin biosynthesis cluster protein F\"}}],\"recommendedName\":{\"ecNumbers\":[{\"evidences\":[{\"evidenceCode\":\"ECO:0000305\",\"id\":\"39105744\",\"source\":\"PubMed\"}],\"value\":\"5.4.99.-\"}],\"fullName\":{\"evidences\":[{\"evidenceCode\":\"ECO:0000303\",\"id\":\"39105744\",\"source\":\"PubMed\"}],\"value\":\"Terpene cyclase resF\"}}}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P0DXW0.json)

```json
{
  "evidence_id": "C5",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/P0DXW0.json",
  "source_sha256": "20826975e15383c7e7ed9a18e9833743bdc1e763a65798dcc5e4dbb145fcc991",
  "retrieved_utc": "2026-11-02T04:29:50.537709+00:00",
  "json_pointer": "/comments/1",
  "excerpt": "{\"commentType\":\"PATHWAY\",\"texts\":[{\"evidences\":[{\"evidenceCode\":\"ECO:0000269\",\"id\":\"39105744\",\"source\":\"PubMed\"}],\"value\":\"Antifungal biosynthesis\"}]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C6

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P0DXW0.json)

```json
{
  "evidence_id": "C6",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/P0DXW0.json",
  "source_sha256": "20826975e15383c7e7ed9a18e9833743bdc1e763a65798dcc5e4dbb145fcc991",
  "retrieved_utc": "2026-11-02T04:29:50.537709+00:00",
  "json_pointer": "/references/0",
  "excerpt": "{\"citation\":{\"authors\":[\"Lu Y.\",\"Li Y.\",\"Dou M.\",\"Liu D.\",\"Lin W.\",\"Fan A.\"],\"citationCrossReferences\":[{\"database\":\"PubMed\",\"id\":\"39105744\"},{\"database\":\"DOI\",\"id\":\"10.1021/acs.jafc.4c04244\"}],\"citationType\":\"journal article\",\"firstPage\":\"18520\",\"id\":\"39105744\",\"journal\":\"J. Agric. Food Chem.\",\"lastPage\":\"18527\",\"publicationDate\":\"2024\",\"title\":\"Discovery of a hybrid molecule with phytotoxic activity by genome mining, heterologous expression, and OSMAC strategy.\",\"volume\":\"72\"},\"referenceNumber\":1,\"referencePositions\":[\"NUCLEOTIDE SEQUENCE [GENOMIC DNA]\",\"FUNCTION\",\"PATHWAY\"]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence H1

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/P0DXW0?format=txt&versions=2)

```json
{
  "evidence_id": "H1",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/P0DXW0?format=txt&versions=2",
  "source_sha256": "4ee0148ff929a45fee99461aa9272fe9ea0eed8e9ecc9ee53739e76044ec61c4",
  "retrieved_utc": "2026-11-02T04:29:54.246056+00:00",
  "source_locator": "lines 1-14",
  "excerpt": "ID   RESF_ASPSL              Reviewed;         342 AA.\nAC   P0DXW0;\nDT   05-FEB-2025, integrated into UniProtKB/Swiss-Prot.\nDT   05-FEB-2025, sequence version 1.\nDT   09-APR-2025, entry version 2.\nDE   RecName: Full=Terpene cyclase resF {ECO:0000303|PubMed:39105744};\nDE            EC=5.4.99.- {ECO:0000305|PubMed:39105744};\nDE   AltName: Full=Restricticin biosynthesis cluster protein F {ECO:0000303|PubMed:39105744};\nGN   Name=resF {ECO:0000303|PubMed:39105744};\nOS   Aspergillus sclerotiorum.\nOC   Eukaryota; Fungi; Dikarya; Ascomycota; Pezizomycotina; Eurotiomycetes;\nOC   Eurotiomycetidae; Eurotiales; Aspergillaceae; Aspergillus;\nOC   Aspergillus subgen. Circumdati.\nOX   NCBI_TaxID=138282;\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 2,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H2

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/P0DXW0?format=txt&versions=2)

```json
{
  "evidence_id": "H2",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/P0DXW0?format=txt&versions=2",
  "source_sha256": "4ee0148ff929a45fee99461aa9272fe9ea0eed8e9ecc9ee53739e76044ec61c4",
  "retrieved_utc": "2026-11-02T04:29:54.246056+00:00",
  "source_locator": "lines 15-21",
  "excerpt": "RN   [1]\nRP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, AND PATHWAY.\nRX   PubMed=39105744; DOI=10.1021/acs.jafc.4c04244;\nRA   Lu Y., Li Y., Dou M., Liu D., Lin W., Fan A.;\nRT   \"Discovery of a hybrid molecule with phytotoxic activity by genome mining,\nRT   heterologous expression, and OSMAC strategy.\";\nRL   J. Agric. Food Chem. 72:18520-18527(2024).\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 2,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H3

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/P0DXW0?format=txt&versions=2)

```json
{
  "evidence_id": "H3",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/P0DXW0?format=txt&versions=2",
  "source_sha256": "4ee0148ff929a45fee99461aa9272fe9ea0eed8e9ecc9ee53739e76044ec61c4",
  "retrieved_utc": "2026-11-02T04:29:54.246056+00:00",
  "source_locator": "lines 37-37",
  "excerpt": "CC   -!- PATHWAY: Antifungal biosynthesis. {ECO:0000269|PubMed:39105744}.\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 2,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

---

Original question/key: [pinned source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/pathway.json), zero-based source row 198. © 2026 LiveProteinBench contributors; [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). [Source credits](../THIRD_PARTY_NOTICES.md).
